ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
- The World Health Organization(WHO) has launched its global strategy for prevention and control of snakebite envenoming.
- WHO Global Strategy targets 50% reduction in mortality and disability caused by snakebite envenoming by 2030.
- This target will be achieved through (a)ensuring access to treatment such as anti-venoms and ancillary medical care by increasing the number of manufacturers by 25% and creating a global antivenom stockpile and (b)encouraging research on new treatments, diagnostics and health device breakthroughs.
- Snakebite envenoming is a neglected tropical disease (NTD).In 2017, WHO had formally categorised “snakebite envenoming” as a Neglected Tropical Disease.
- Snake bite affects 1.8–2.7 million people each year.It is a neglected public health issue in many tropical and subtropical countries such as Africa, Asia and Latin America.
- Further,most deaths and serious consequences from snake bites are entirely preventable by making High quality snake antivenoms accessible.They are included in the WHO List of essential medicines.



